Clinical features and outcomes in adults with COVID-19 during the pre-Omicron and Omicron waves

被引:3
|
作者
Martinot, M. [1 ,4 ]
Schieber, A. [2 ]
Ongagna, J. C. [2 ]
Henric, A. [2 ]
Eyriey, M. [2 ]
Mohseni-Zadeh, M. [1 ]
Ion, C. [1 ]
Demesmay, K. [3 ]
Gravier, S. [1 ]
Kempf, C. [2 ]
机构
[1] Hop Civils Colmar, Infect Dis Dept, Colmar, France
[2] Hop Civils Colmar, Clin Res Dept, Colmar, France
[3] Hop Civils Colmar, Pharm Dept, Colmar, France
[4] Hop Civils Colmar, Infect Dis Dept, 39 Ave Liberte, F-68024 Colmar, France
来源
INFECTIOUS DISEASES NOW | 2024年 / 54卷 / 02期
关键词
COVID-19; SARS-CoV-2; variants; Outcome; Mortality; Nosocomial cases; TRANSMISSION; SARS-COV-2; HEALTH;
D O I
10.1016/j.idnow.2023.104833
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: We conducted a single-center retrospective study to compare patient characteristics and death rates during the Omicron (O, December 01, 2021, to September 30, 2022) and pre-Omicron (PO, March 01, 1920, to October 31, 2021) periods.Patients and Methods: We retrospectively analyzed the data of 2932 patients (1242 (O) and 1690 (PO)) hospitalized (>24 h) with laboratory-confirmed COVID.Results: Compared to the PO period, O period patients were less frequently men, had a lower body mass index and fewer comorbidities except for immunosuppression and pregnancy. Nosocomial COVID-19 accounted for 18.2 % (O) and 15.4 % (PO) of cases (p = 0.05). Patient mortality rates during the O and PO periods were 11.0 % and 16.9 % (p < 0.001), respectively. Unvaccinated status (p < 0.001), existence of comorbidities, (p < 0.001) and high LDH value at baseline (p = 0.015), but not the period, were identified as factors likely to explain death.Conclusion: During the Omicron period, the inpatient death rate remained > 10 %, especially among unvaccinated and comorbid patients. Nosocomial cases were more frequent.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19
    Faust, Jeremy Samuel
    Du, Chengan
    Liang, Chenxue
    Mayes, Katherine Dickerson
    Renton, Benjamin
    Panthagani, Kristen
    Krumholz, Harlan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (01): : 74 - 76
  • [22] Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review
    Paul, Pradipta
    El-Naas, Ahmed
    Hamad, Omar
    Salameh, Mohammad A.
    Mhaimeed, Nada
    Laswi, Ibrahim
    Abdelati, Ali A.
    AlAnni, Jamal
    Khanjar, Bushra
    Al-Ali, Dana
    Pillai, Krishnadev V.
    Elshafeey, Abdallah
    Alroobi, Hasan
    Burney, Zain
    Mhaimeed, Omar
    Bhatti, Mohammad
    Sinha, Pratyaksha
    Almasri, Muna
    Aly, Ahmed
    Bshesh, Khalifa
    Chamseddine, Reem
    Khalil, Omar
    D'Souza, Ashton
    Shree, Thanu
    Mhaimeed, Narjis
    Yagan, Lina
    Zakaria, Dalia
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [23] Wild type through omicron: obstetric outcomes across COVID-19 waves
    Parikh, Bijal
    Pattanaik, Rakasa
    Shinder, Eliane
    Heiselman, Cassandra
    Garretto, Diana
    Garry, David
    Herrera, Kimberly
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S443 - S443
  • [24] Wild type through Omicron: Maternal outcomes across COVID-19 waves
    Parikh, Bijal
    Shinder, Eliane
    Pattanaik, Rakasa
    Herrera, Kimberly
    Garretto, Diana
    Garry, David
    Heiselman, Cassandra
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S99 - S100
  • [25] Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period
    Murakami, Yasushi
    Nozaki, Yasuhiro
    Morosawa, Mika
    Toyama, Masanobu
    Ogashiwa, Hitoshi
    Ueda, Takashi
    Nakajima, Kazuhiko
    Tanaka, Ryoya
    Takesue, Yoshio
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (09) : 853 - 859
  • [26] Risk of long Covid in children infected with Omicron or pre-Omicron SARS-CoV-2 variants
    Buonsenso, Danilo
    Morello, Rosa
    Mariani, Francesco
    De Rose, Cristina
    Mastrantoni, Luca
    Zampino, Giuseppe
    Valentini, Piero
    ACTA PAEDIATRICA, 2023, 112 (06) : 1284 - 1286
  • [27] COVID-19 Outcomes in Kidney Transplant During in the Period of Omicron Predominance
    Bernardo, Joao F.
    Goncalves, Sara
    Rodrigues, Natacha
    Santos, Noelia L.
    Goncalves, Joao A.
    Abreu, Fernando
    Neves, Marta R.
    Santana, Alice
    Lopes, Jose A.
    Godinho, Iolanda
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 319 - 319
  • [28] Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
    Arbel, Ronen
    Sagy, Yael Wolff
    Hoshen, Moshe
    Battat, Erez
    Lavie, Gil
    Sergienko, Ruslan
    Friger, Michael
    Waxman, Jacob G.
    Dagan, Noa
    Balicer, Ran
    Ben-Shlomo, Yatir
    Peretz, Alon
    Yaron, Shlomit
    Serby, Danielle
    Hammerman, Ariel
    Netzer, Doron
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (09): : 790 - 798
  • [29] Antibodies against SARS-CoV-2 in unvaccinated children hospitalized with COVID-19: An observational cohort study of pre-Omicron and Omicron variants era
    Uppala, Rattapon
    Sitthikarnkha, Phanthila
    Faksri, Kiatichai
    Kosalaraksa, Pope
    Techasatian, Leelawadee
    Tantawarak, Nattakarn
    Nanthavongsa, Sysavanh
    PLOS ONE, 2024, 19 (02):
  • [30] Characteristics and clinical outcomes of patients with COVID-19 recurrent infection during the omicron variant predominance
    Abuhasira, Ran
    Burrack, Nitzan
    Nesher, Lior
    Ostrovsky, Daniel
    Novack, Victor
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 114 : 131 - 134